「therapeutics」の共起表現一覧(1語右で並び替え)

therapeutics

1語右で並び替え

該当件数:61件

  • r textbook On the position and prospects of therapeutics: a lecture introductory to a course on mate
  • In December 2007, the microRNA therapeutics activities were moved into a new entity cal
  • t pathology in New Zealand, especially with therapeutics and naming of pathogens.
  • ofessor of pathology, in 1719, professor of therapeutics and permanent dean of the Faculty of Medici
  • 1859, the year when Quin took the chair of therapeutics and materia medica in the medical school.
  • al committee of RF for the viral infections therapeutics and prophylaxis (flu, hepatitis A, B, herpe
  • irector of the Seligman Center for Advanced Therapeutics and the Behcet's Syndrome Evaluation, Treat
  • macists, having served on the Commission on Therapeutics and the Task Force on Science.
  • y, Journal of Pharmacology and Experimental Therapeutics, and Surgical Infections.
  • gen Ltd, ProKyma Technologies Ltd, Sherwood Therapeutics and P2i Ltd.
  • g in the discovery and development of novel therapeutics and diagnostics using synthetic DNA, that m
  • ld Department of Applied Materia Medica and Therapeutics and ended up establishing the Department of
  • These types of therapeutics are based on elimination therapy.
  • ositol is under investigation by Transition Therapeutics as a disease-modifying therapy for Alzheime
  • CRUK Centre for Cancer Therapeutics at the Institute for Cancer Research
  • oratory for Tissue Engineering and Cellular Therapeutics at the Harvard Children's Hospital.
  • 862; he was professor of materia medica and therapeutics at Dartmouth College from 1871 to 1887 and
  • A consultant physician and professor of therapeutics at Nottingham University since 1987, he cha
  • Halozyme Therapeutics, based in San Diego, California, is a bioph
  • ntial that correct information on drugs and therapeutics be given to all medical personnel and also
  • received grant/research support from Acorda Therapeutics, Biogen Idec, Genzyme, Novartis, and Teva N
  • nd Director for the Centre for Genome-based Therapeutics, Cardiff University, UK (2002-2006).
  • No approved therapeutics contain ricin.
  • f automated sequencing & software to Genome Therapeutics Corp. resulted in the first commercial geno
  • hnology & Innovation Council; and Stem Cell Therapeutics Corp.
  • a City Councilman with the creation of the Therapeutics Division of the Parks and Recreation Depart
  • man & Gilman's The Pharmacological Basis of Therapeutics, ed. 10 from McGraw Hill Medical Publishing
  • laway's laboratory discovered potential new therapeutics for Alzheimer's disease based upon apomorph
  • e, test and introduce new or higher quality therapeutics for humans.
  • olecular Medicine for Everyone: Megavitamin Therapeutics for Families and Physicians (Vol 2), Laguna
  • 1976 with a diploma in speech Pathology and Therapeutics from the College of Education in Leicester.
  • f prosthetic dentistry, materia medica, and therapeutics, he published 43 dental research articles i
  • of the BMP family are potentially useful as therapeutics in areas such as spinal fusion.
  • These cytokines are used as therapeutics in many diseases such as chronic viral infe
  • ed to the rank of Professor of Medicine and Therapeutics in 1998.
  • established the Ansary Center for Stem Cell Therapeutics in 2004 in honor of a grant from Ansary and
  • s called to the chair of materia medica and therapeutics in the New York Medical College.
  • n HESL worked in biomedical diagnostics and therapeutics, in environmental assessment and remediatio
  • ruction August 5, 2008), occupied by Nektar Therapeutics in November 2010 as their corporate headqua
  • iCo Therapeutics Inc. renamed the drug from CAT-213 to iCo-0
  • IL Therapeutics Inc. was previously owned by Western Life S
  • es, FoldRx Pharmaceuticals and Proteostasis Therapeutics, Inc. (with Andrew Dillin and Richard Morim
  • Insert Therapeutics, Inc., now Calando Pharmaceuticals, Inc., i
  • g for treatment of allergy disorders to iCo Therapeutics Inc.. iCo Therapeutics Inc. is a Vancouver-
  • Currently IL Therapeutics is working on a drug candidate, IL-8(3-73)K
  • Developed by Orchestra Therapeutics, it is currently in phase II clinical trial
  • lso by challenging the effectiveness of the therapeutics of the day.
  • Professor of the Department of Medicine and Therapeutics of the Chinese University of Hong Kong, and
  • onounced a "milestone" by the Developmental Therapeutics Program of the National Cancer Institute, f
  • tional Medical Centre is part of the Cancer Therapeutics Research Group (CTRG), a research collabora
  • eventual target is the development of novel therapeutics that will promote healing while reducing sc
  • The company is focused on therapeutics that deliver a cancer-destroying drug direc
  • efficacious but cost effective vaccines and therapeutics that are within the reach of the common man
  • Neurovax is currently on hold, as Orchestra Therapeutics, the organization responsible for the drug,
  • However, in the area of therapeutics, the Eclectics carried on a rigorous campai
  • ansferred a number of biologically produced therapeutics to CDER.
  • It is marketed by Sirion Therapeutics under the tradename Durezol.
  • site is now being utilized for delivery of therapeutics via fusion proteins.
  • IL Therapeutics was developed from research first begun at
  • cal practice, and a “Report upon Advance in Therapeutics,” which was printed in the Transactions of
  • sprudence and accepted that of medicine and therapeutics, which he held until 1877; at the same time